641 results for "krytan tek side effects"

Search for:

Date Range to

641 Results on GlaucomaToday.com

December 2016December 2016

Preservative-Free Alternatives Options for decreasing ocular toxicity in patients with glaucoma.
By Arkadiy Yadgarov, MD, and Reena A. Garg, MD

On The Horizon New medications give fresh hope for treating glaucoma.
By Jason Bacharach, MD

Sustained-Release Drug Delivery: the Future of Glaucoma Treatment Several devices are being investigated.
By Justin A. Schweitzer, OD, FAAO, and Mitch Ibach, OD, FAAO

Industry News

Phaco-Goniosynechialysis: Tap, Sweep, and Tweep By Jonathan S. Myers, MD

Fixed Combinations A mainstay of glaucoma management today and tomorrow.
By Robert D. Fetchner, MD, and Albert S. Khouri, MD

From the Trenches What is maximal medical therapy today? Three physicians share their thoughts.
By Howard Barnebey, MD; Carla J. Siegfried, MD; and Julia Song, MD

The Adherence Problem Its scope and strategies for its reduction.
By Henry D. Jampel, MD, MHS

The Literature By Jonathan Paul, MD, and Sheila Sanders, MD

Glaucoma in the Octogenarian Considerations in treating the advanced elderly.
By Samuel P. Solish, MD

October 2016October 2016

Cataract Surgery Alone—an Underused Solution? One of the most common ophthalmic surgical tools achieves more than its primary intended purpose.
By Nicholas Bell, MD

Suprachoroidal Access: the Next Big Thing? This new class of devices will allow further customization of glaucoma therapy.
By Cynthia Mattox, MD

Gonioscopy Is Essential for MIGS This critical skill set comprises more than docking the goniolens.
By Shakeel Shareef, MD

Tools of the Trade Instruments essential to any successful trabeculectomy.
By Jon M. Ruderman, MD, and Sara R. Ghobraiel, MD

MIGS in Kids Recent advances may reshape the traditional paradigm.
By Ta Chen Peter Chang, MD

Industry News

The Results Are in: 2016 Film Festival Winner Announced Congratulations to Shakeel Shareef, MD, the winner of the GT 2016 Film Festival.

To the FDA With Appreciation By Steven D. Vold, MD

August 2016August 2016

The Literature By Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD

What Is the Real IOP? Laboratory studies may help us better understand our clinical dilemmas.
By Dan Eisenberg, MD

Highlights of the 2016 ARVO Annual Meeting Select research findings presented this year.
By Sze H. Wong, MD, and Albert S. Khouri, MD

News Feature: a New Option for Uveitis Adalimumab, a rheumatology drug, offers hope to patients with this damaging inflammatory eye disease.
By Agustin L. Gonzalez, OD

Glaucoma After Corneal Limbal Stem Cell Transplantation By Ahmad A. Aref, MD; Kavitha R. Sivaramen, MD; and Ali R. Djalilian, MD

Foundations of a Great Physician By Linda Huang, MD

Ocular Surface Disease: Impact on Glaucoma Surgical Decision Making The preoperative planning process is more complex and requires careful attention to the unique issues at play.
By Tony Realini, MD, MPH

The Dark Side of Medication Many systemic and topical drugs can cause or worsen dry eye disease.
By Sarah Marshall, PhD, and Robert Noecker, MD, MBA

Tear Osmolarity in a Glaucoma Practice The role of point-of-care testing in dry eye disease and glaucoma management.
By Leslie E. O’Dell, OD

Corneal Imaging The principles and clinical significance of various technologies.
By Alice T. Epitropoulos, MD

Intense Pulsed Light for Dry Eye Disease This procedure improves the health of the meibomian glands.
By Rolando Toyos, MD

What Every Glaucoma Doctor Should Know About DED New technologies provide more information and better outcomes than ever before.
By Sheri Rowen, MD

Punctal Occlusion and Ocular Nutrition By Paul S. Koch, MD, and Thandeka Myeni, MD, MPH

FDA Approves New Drug for Dry Eye Disease

Neurostimulation: a Novel Approach to Treating the Signs and Symptoms of Dry Eye A device in clinical study could lead to new understanding of dry eye as a neuronal disease.
By John Berdahl, MD

Being a Doctor, Thinking Like a CEO The merging of two mindsets requires skill, versatility, and sensitivity.
By Wolfgang Riha, MD

June 2016June 2016

The Literature By Reena A. Garg, MD, and Helen Jiang, MD

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP By Robert Chang, MD, and Kuldev Singh, MD, MPH

The Eyes of Africa Project Partners bring comprehensive eye care to rural Malawi.
By William Eric Sponsel, MD

Assessing Corneal Biomechanics The importance of these properties rests primarily with their effects on IOP measurement.
By Leon W. Herndon, MD

Evaluating Quality of Life in Glaucoma Understand the impact of the disease to improve care.
By Felipe A. Medeiros, MD, PhD

Do We Need Perimetry? As glaucoma advances, visual field testing provides valuable insight.
By Murray Fingeret, OD

12345678910111213141516 | Next >